Memorial Sloan Kettering Cancer Center (MSK) is a leading institution dedicated to ending cancer for life through specialized, compassionate care and innovative research. With a mission to improve the prevention, diagnosis, and treatment of cancer, MSK's teams collaborate closely with the Sloan Kettering Institute to translate scientific discoveries into clinical advancements. The center is committed to training the next generation of scientists and clinicians, fostering a diverse and inclusive environment. MSK offers a range of clinical trials and research opportunities, exemplified by initiatives like the Prostate Cancer Clinical Trials Consortium (PCCTC), which focuses on hypothesis-driven trials to enhance patient care. The organization values collaboration, attention to detail, and a commitment to excellence in patient care and research.